Source Details

{
    "source_type": "extension",
    "content_hash": "e5256d63738a06aad82ae933f1839f37f473ced160e7428ca4a6754875ac3e4d",
    "submitted_via": "chrome_extension",
    "extension_version": "1.0.18",
    "original_url": "https:\/\/www.nytimes.com\/2026\/10\/01\/science\/pike-execution-pentobarbital.html?emc=edit_nn_20261002&nl=the-morning&segment_id=227407&smid=url-share",
    "parsed_content": "Christa Pike\u2019s Botched ExecutionWhat to KnowHow Did Pike Survive?Video: Pike Feared Botched ExecutionExecution History in the U.S.AdvertisementSKIP ADVERTISEMENTSupported bySKIP ADVERTISEMENTHow Did Christa Pike Survive Two Lethal Injections of Pentobarbital?A catheter carrying the drug may not have delivered the doses to Ms. Pike\u2019s bloodstream, experts said. The drug itself may have been degraded.Listen \u00b7 8:44 min Share full articleVideo\u2018This Is Awful,\u2019 Christa Pike\u2019s Lawyer Says About Botched ExecutionRandy Spivey, one of Christa Pike\u2019s lawyers, said that Pike remained in critical condition on Thursday after a botched execution attempt the night before.CreditCredit...George Walker IV\/Associated PressBy Benjamin Mueller and Shaila DewanOct. 1, 2026Leer en espa\u00f1olSee more of our coverage in your search results.Encuentra m\u00e1s de nuestra cobertura en los resultados de b\u00fasqueda. Add The New York Times on GoogleAgrega The New York Times en Google The execution team went through at least seven needles trying to find a vein suitable for delivering doses of a lethal drug to Tennessee inmate Christa Pike, her lawyers said on Thursday. Ms. Pike, who survived the botched execution on Wednesday night, was left with blistering and burning around the intravenous insertion sites that the execution team ultimately used to deliver the drug, the lawyers added.Those details reinforced the sense among outside medical experts that Ms. Pike had survived the procedure because the drug, pentobarbital, probably poured into tissue surrounding the insertion sites instead of entering her bloodstream.That could have prevented the drug from reaching the levels needed in her circulatory system to stop her breathing.AdvertisementSKIP ADVERTISEMENTThe drug may nonetheless have lowered her oxygen levels or weakened her circulation enough to cause permanent brain damage. Any leak of the drug into her tissue could also have caused chemical burns.Ms. Pike\u2019s lawyers said she was in critical condition and receiving lifesaving medical care. Stephen Ferrell, one of her lawyers, said that while details of the execution attempt were consistent with there having been problems with the intravenous delivery, a number of other factors could have been involved.The Tennessee Department of Correction said in a statement on Wednesday night that it \u201chad followed every step of the state\u2019s lawful, established execution protocol approved by the attorney general\u2019s office.\u201d Officials did not answer questions on Thursday about what went wrong with the administration of the drug.Medical experts said there were signs that the two intravenous catheters, rather than directing the drug into Ms. Pike\u2019s bloodstream, had allowed it to leak into the tissue surrounding the insertion point.That could have been because of how or where the catheters were inserted, the fragility of Ms. Pike\u2019s veins, or for another reason. Her lawyers said that doctors had always had difficulty finding veins during her blood draws and that Ms. Pike has a blood disorder that exacerbates that problem.AdvertisementSKIP ADVERTISEMENTDuring the execution attempt, they added, Ms. Pike even tried to help the staff place the two IV lines.\u201cShe over and over again said, \u2018Please, try up on my shoulder higher, please try here, please try here,\u2019\u201d Randy Spivey, another of her lawyers, said. He added that Ms. Pike thanked them once staff members thought they had established the two lines.Instances in which intravenous drugs leak into tissue under the skin are known as \u201cIV infiltration,\u201d and have been cited in past botched executions, including ones that caused extensive chemical burns. Experts said that experienced doctors in a medical setting would typically be able to recognize signs of an IV infiltration as it occurred.Members of the news media who served as witnesses to the execution attempt said that Ms. Pike at one point described a burning spot in her arm that felt as if it were going to burst and asked if that was normal.AdvertisementSKIP ADVERTISEMENT\u201cThe pain in her arm should have been a bright red flag that the IV was infiltrating,\u201d said Dr. Mark Heath, an assistant professor of anesthesiology at Columbia University Irving Medical Center.ImageA vial of pentobarbital.Credit...Department of Justice, via Associated PressDr. Joel Zivot, a professor of anesthesiology at the Emory University School of Medicine who said that he had previously been retained by Ms. Pike\u2019s lawyers as a medical expert, said that such an event would have caused the type of reaction that witnesses described.The result, he said, could have been a highly alkaline solution leaking into Ms. Pike\u2019s arm. \u201cEssentially, they\u2019ve injected bleach into the tissue of her arm,\u201d Dr. Zivot said.He added that he was speaking on his own behalf and not for Ms. Pike\u2019s legal team, and that he had no direct knowledge of what happened during the execution attempt.AdvertisementSKIP ADVERTISEMENTHaving examined Ms. Pike\u2019s medical records before the execution attempt, Dr. Zivot said that she was also susceptible to an IV infiltration. Ms. Pike\u2019s lawyers had previously argued that the procedure could be agonizing for her in part because she has small veins.\u201cHer venous system was small, and there could be some fragility there,\u201d Dr. Zivot said. \u201cYou push a lot of a caustic substance into a small vein like that, under pressure, it\u2019s going to blow.\u201dHe said chemical properties of the lethal drug, pentobarbital, mean that it can burn tissue and skin during executions.Pentobarbital is a barbiturate that can treat seizures; it works by depressing activity in the nervous system. It is a mainstay drug for euthanizing animals. The drug has also been used in states with legal medical aid in dying.Its main effect is to shut down electrical activity in the brain, including neurons in the brainstem that control breathing. The body enters a coma-like state, followed by respiratory failure and cardiac arrest.AdvertisementSKIP ADVERTISEMENTThe federal government adopted single-drug pentobarbital for lethal injections during the first Trump administration.Under President Biden, the protocol was rescinded after a review by the Justice Department in January 2025 concluded that there remained \u201csignificant uncertainty\u201d about whether using the drug for lethal injections \u201ccauses unnecessary pain and suffering.\u201dPresident Trump\u2019s current administration has reinstated its use, and has said it will also use firing squads.In Ms. Pike\u2019s case, medical experts said it was also possible that there had been something wrong with the pentobarbital itself.The primary manufacturer of pentobarbital has restricted the drug\u2019s use in executions, the Justice Department review noted. As a result, states have turned to chemical companies and compounding pharmacies, which are more loosely regulated.AdvertisementSKIP ADVERTISEMENT\u201cIs it possible that the pentobarbital itself was somehow not constituted properly?\u201d Dr. Zivot said. \u201cCould it have degraded? Could it have expired? All of those things are possible.\u201dAlmost as soon as lethal injection was first adopted in the United States in the late 1970s as a more medicalized, less painful method of execution, there were prolonged or botched executions.In part, that was because the injections were often administered by correctional workers with limited medical training. Most doctors and anesthesiologists declined to advise or participate on ethical grounds.In 2009, the maker of one of the key drugs, sodium thiopental, stopped production in the United States. Other drug companies prohibited the use of their products for executions.States began scrambling to obtain the drugs, turning to compounding pharmacies and resorting to legally questionable arrangements like loaning the drugs to one another and importing drugs labeled for veterinary use. At one point, the Drug Enforcement Administration even seized Georgia\u2019s supply of lethal injection drugs.AdvertisementSKIP ADVERTISEMENTPrisoners argued in court that lethal injection did not eliminate pain and suffering, but only masked it. \u201cIt is not the most humane, it is the most humane-looking,\u201d said Corinna Lain, a law professor and the author of \u201cSecrets of the Killing State: the Untold Story of Lethal Injection,\u201d published last year. In response to the controversies, states shrouded the process in secrecy, passing laws that kept the public from learning details such as how the drugs are obtained and what dosage is used.Ms. Pike\u2019s lawyers said on Thursday that they hoped records would be preserved that would allow them to learn how her execution had gone wrong. They said they had long warned in court that Ms. Pike\u2019s medical conditions could cause problems, but that those warnings went unheeded.Mr. Spivey, her lawyer, said that among the at least seven needles used to try to establish an IV line in Ms. Pike\u2019s left arm alone was one that appeared to be bent when it was pulled from her arm after an unsuccessful attempt.Whatever the reason the execution failed, medical experts said, the possibility that Ms. Pike had suffered the effects of a nonfatal dose of pentobarbital for an extended period created a risk for lasting brain injury.\u201cShe could be facing profound medical complications,\u201d Dr. Zivot said.AdvertisementSKIP ADVERTISEMENT",
    "published_at": "2026-10-01T17:51:04+00:00",
    "author_name": "Benjamin Mueller, Shaila Dewan",
    "site_name": "The New York Times",
    "section": "Science",
    "publisher": "The New York Times Company",
    "ai_headline": "Christa Pike\u2019s Botched Execution: How Did She Survive Two Lethal Injections of Pentobarbital?",
    "ai_simplified_title": "Christa Pike Survives Botched Execution After Two Lethal Injections",
    "ai_excerpt": "Christa Pike survived a botched execution attempt involving two lethal injections of pentobarbital, likely due to IV infiltration or degraded drugs. Experts suggest she may suffer permanent brain damage or chemical burns.",
    "ai_subject_tags": [
        "Christa Pike",
        "Lethal Injection",
        "Botched Execution",
        "Pentobarbital",
        "Capital Punishment",
        "Medical Ethics",
        "Tennessee"
    ],
    "ai_context_type": "News",
    "ai_context_details": {
        "tone": "informative",
        "perspective": "neutral",
        "audience": "general",
        "credibility_indicators": [
            "expert_quotes"
        ]
    },
    "ai_source_vector": null,
    "ai_confidence_score": 0.9999999999999999,
    "ai_extraction_metadata": {
        "extracted_at": "2026-10-02T12:01:51.250420Z",
        "ai_model": "gemini-2.5-flash",
        "extraction_method": "automated",
        "content_length": 9415,
        "metadata_prompt_body_chars": 9415,
        "metadata_prompt_truncated": false,
        "url": "https:\/\/nytimes.com\/2026\/10\/01\/science\/pike-execution-pentobarbital.html",
        "existing_metadata": {
            "author_name": null,
            "published_at": null,
            "domain_name": "nytimes.com",
            "site_name": null,
            "section": null,
            "publisher": null
        },
        "openai_refusal_gemini_fallback": false
    }
}

{
    "extracted_at": "2026-10-02T12:01:51.250420Z",
    "ai_model": "gemini-2.5-flash",
    "extraction_method": "automated",
    "content_length": 9415,
    "metadata_prompt_body_chars": 9415,
    "metadata_prompt_truncated": false,
    "url": "https:\/\/nytimes.com\/2026\/10\/01\/science\/pike-execution-pentobarbital.html",
    "existing_metadata": {
        "author_name": null,
        "published_at": null,
        "domain_name": "nytimes.com",
        "site_name": null,
        "section": null,
        "publisher": null
    },
    "openai_refusal_gemini_fallback": false
}